Author

Lena Litzenburger

Karolinska Institutet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alena MalyukovaiD· 1 shared Alessandro Simone BordonaroiD· 1 shared Andrä BrunneriD· 1 shared Conny TümmleriD· 1 shared Ervelina Dalani· 1 shared Georgios MermelekasiD· 1 shared Glenn M. MarshalliD· 1 shared Janith Seniveratne· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alena MalyukovaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting the FBXL12-FANCD2 Pathway Disrupts Replication Stress Tolerance in MYCN-Driven Neuroblastoma

Jinjiang Chou, Alena Malyukova, Alessandro Simone Bordonaro, Krzysztof Dygon, Lena Litzenburger, Ervelina Dalani, Jiayu Xiao, Conny Tümmler, Georgios Mermelekas, Janith Seniveratne, Magdalena Paolino, Juha Rantala, Lukas M. Orre, Glenn M. Marshall, John Inge Johnsen, , Olle Sangfelt

This study identifies the FBXL12-FANCD2 pathway as a vulnerability in MYCN-driven neuroblastoma, showing its role in replication stress tolerance and potential as a therapeutic target.

bioRxiv · Aug 31, 2026 · PreprintCancer Biology